Literature DB >> 23101423

The cardiorenal syndrome: a mutual approach to concomitant cardiac and renal failure.

Jeremy Ben-Shoshan1, Michal Entin-Meer, Hanan Guzner-Gur, Gad Keren.   

Abstract

Heart failure (HF) accompanied by renal failure, termed cardiorenal syndrome (CRS), encompasses both the development and worsening of renal insufficiency secondary to HF as well as the harmful effects of impaired renal function on the cardiovascular system, and remains a universalclinical challenge. CRS was recently classified into subtypes depending on the etiologic and chronologic interactions between cardiac and renal dysfunctions. The mechanisms underlying the CRS are multifactorial, including hemodynamic alterations, neurohormonal effects, and inflammatory components. However, despite enhanced understanding and awareness of CRS, further elucidation of the mechanisms involved and the appropriate treatment approaches are clearly warranted. CRS is a difficult condition to manage, as treatment to relieve congestive symptoms of HF is limited by a further decline in renal functions, itself a major independent predictor of long-term cardiac morbidity. In order to perform a proper clinical investigation and implement appropriate treatmentthat will minimize subsequent progression of heart and kidney injury, a comprehensive approach to these two pathologies is crucial. In the present review we discuss current theories behind the mechanistic evolution of the CRS as well as therapeutic issues regarding this multifaceted condition.

Entities:  

Mesh:

Year:  2012        PMID: 23101423

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  3 in total

1.  Myocardial infarction worsens glomerular injury and microalbuminuria in rats with pre-existing renal impairment accompanied by the activation of ER stress and inflammation.

Authors:  Zhifeng Dong; Penglong Wu; Yongguang Li; Yuan Shen; Ping Xin; Shuai Li; Zhihua Wang; Xiaoyan Dai; Wei Zhu; Meng Wei
Journal:  Mol Biol Rep       Date:  2014-08-31       Impact factor: 2.316

Review 2.  The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation.

Authors:  John G Kingma; Denys Simard; Jacques R Rouleau; Benoit Drolet; Chantale Simard
Journal:  J Cardiovasc Dev Dis       Date:  2017-11-29

3.  Cystatin C, N-terminal probrain natriuretic peptides and outcomes in acute heart failure with acute kidney injury in a 12-month follow-up: Insights into the cardiorenal syndrome.

Authors:  Zhong-Bao Ruan; Li Zhu; Yi-Gang Yin; Ge-Cai Chen
Journal:  J Res Med Sci       Date:  2014-05       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.